{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:36:24Z","timestamp":1782992184699,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010104","name":"Tianjin Medical University","doi-asserted-by":"publisher","award":["2018kylc004"],"award-info":[{"award-number":["2018kylc004"]}],"id":[{"id":"10.13039\/501100010104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.lfs.2025.123585","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T04:38:40Z","timestamp":1743136720000},"page":"123585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["CELF2 inhibits bladder cancer progression by decreasing the stability of CXCL5"],"prefix":"10.1016","volume":"370","author":[{"given":"Shiqiang","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingkun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lfs.2025.123585_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.lfs.2025.123585_bb0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","article-title":"Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice","volume":"20","author":"van Hoogstraten","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.lfs.2025.123585_bb0015","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1093\/nar\/24.22.4407","article-title":"Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy","volume":"24","author":"Timchenko","year":"1996","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.123585_bb0020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/wrna.107","article-title":"The importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins","volume":"3","author":"Dasgupta","year":"2012","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.lfs.2025.123585_bb0025","series-title":"The Role of CELF2 in the Signal Induced Alternative Splicing of LEF1 Exon 6 in T Cells","author":"Ajith","year":"2015"},{"issue":"3","key":"10.1016\/j.lfs.2025.123585_bb0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1097-2765(02)00479-3","article-title":"Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing","volume":"9","author":"Charlet","year":"2002","journal-title":"Mol. Cell"},{"issue":"20","key":"10.1016\/j.lfs.2025.123585_bb0035","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1093\/nar\/gkq573","article-title":"CELF proteins regulate CFTR pre-mRNA splicing: essential role of the divergent domain of ETR-3","volume":"38","author":"Dujardin","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.lfs.2025.123585_bb0040","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/jnr.20980","article-title":"ETR-3 represses tau exons 2\/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I","volume":"84","author":"Leroy","year":"2006","journal-title":"J. Neurosci. Res."},{"issue":"2","key":"10.1016\/j.lfs.2025.123585_bb0045","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.molcel.2017.03.014","article-title":"A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis","volume":"66","author":"Treiber","year":"2017","journal-title":"Mol Cell."},{"issue":"1","key":"10.1016\/j.lfs.2025.123585_bb0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1097-2765(03)00012-1","article-title":"Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2","volume":"11","author":"Mukhopadhyay","year":"2003","journal-title":"Mol. Cell"},{"issue":"50","key":"10.1016\/j.lfs.2025.123585_bb0055","doi-asserted-by":"crossref","first-page":"47338","DOI":"10.1074\/jbc.M104911200","article-title":"Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor","volume":"276","author":"Anant","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2025.123585_bb0060","doi-asserted-by":"crossref","first-page":"G53","DOI":"10.1152\/ajpgi.00118.2006","article-title":"ApoB mRNA editing is mediated by a coordinated modulation of multiple apoB mRNA editing enzyme components","volume":"292","author":"Chen","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123585_bb0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1158\/0008-5472.34.65.1","article-title":"High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors","volume":"65","author":"Koed","year":"2005","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.lfs.2025.123585_bb0070","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3892\/ijo_00000222","article-title":"Progressive increase of genetic alteration in urinary bladder cancer by combined allelotyping analysis and comparative genomic hybridization","volume":"34","author":"Chan","year":"2009","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.lfs.2025.123585_bb0075","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1128\/MCB.25.3.879-887.2005","article-title":"Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment","volume":"25","author":"Faustino","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123585_bb0080","doi-asserted-by":"crossref","first-page":"G1025","DOI":"10.1152\/ajpgi.00602.2007","article-title":"Translation inhibition during cell cycle arrest and apoptosis: mcl-1 is a novel target for RNA binding protein CUGBP2","volume":"294","author":"Subramaniam","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2025.123585_bb0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.omtn.2020.10.011","article-title":"The RNA-binding protein CELF2 inhibits ovarian Cancer progression by stabilizing FAM198B","volume":"23","author":"Guo","year":"2021","journal-title":"Mol. Ther. Nucleic. Acids"},{"issue":"1","key":"10.1016\/j.lfs.2025.123585_bb0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12943-017-0629-4","article-title":"Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK\/Elk-1\/Snail and AKT\/GSK3\u03b2\/\u03b2-catenin pathways","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.lfs.2025.123585_bb0095","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1038\/sj.onc.1207260","article-title":"High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization","volume":"23","author":"Hurst","year":"2004","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.lfs.2025.123585_bb0100","doi-asserted-by":"crossref","first-page":"G1235","DOI":"10.1152\/ajpgi.00037.2008","article-title":"CUGBP2 downregulation by prostaglandin E2 protects colon cancer cells from radiation-induced mitotic catastrophe","volume":"294","author":"Natarajan","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123585_bb0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7178\/ig.1.1.7","article-title":"Reduced expression of RNA binding protein CELF2, a putative tumor suppressor gene in Colon Cancer","volume":"1","author":"Ramalingam","year":"2012","journal-title":"Immunogastroenterology"},{"key":"10.1016\/j.lfs.2025.123585_bb0110","doi-asserted-by":"crossref","unstructured":"Subramaniam D, Ramalingam S, Linehan DC, et al. RNA binding protein CUGBP2\/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells. PLoS One. Feb 11 2011;6(2):e16958. doi:https:\/\/doi.org\/10.1371\/journal.pone.0016958.","DOI":"10.1371\/journal.pone.0016958"},{"issue":"1","key":"10.1016\/j.lfs.2025.123585_bb0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00423-015-1364-1","article-title":"Upregulation of cugbp2 increases response of pancreatic cancer cells to chemotherapy","volume":"401","author":"Jakstaite","year":"2016","journal-title":"Langenbeck\u2019s Arch. Surg."},{"issue":"3","key":"10.1016\/j.lfs.2025.123585_bb0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgz113","article-title":"CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction","volume":"41","author":"Yeung","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2025.123585_bb0125","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.biopha.2018.02.104","article-title":"miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer","volume":"101","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2025.123585_bb0130","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1196\/annals.1299.093","article-title":"CUGBP2 plays a critical role in apoptosis of breast cancer cells in response to genotoxic injury","volume":"1010","author":"Mukhopadhyay","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"45","key":"10.1016\/j.lfs.2025.123585_bb0135","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1038\/s41388-019-0936-x","article-title":"Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer","volume":"38","author":"Piqu\u00e9","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2025.123585_bb0140","doi-asserted-by":"crossref","unstructured":"Suman M, Dugu\u00e9 PA, Wong EM, et al. Association of variably methylated tumour DNA regions with overall survival for invasive lobular breast cancer. Clin EpigeneticsJan 18 2021;13(1):11. doi:https:\/\/doi.org\/10.1186\/s13148-020-00975-6.","DOI":"10.1186\/s13148-020-00975-6"},{"issue":"5","key":"10.1016\/j.lfs.2025.123585_bb0145","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.3817","article-title":"A single-copy sleeping beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes","volume":"49","author":"de la Rosa","year":"2017","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.lfs.2025.123585_bb0150","first-page":"2977","article-title":"STYXL1 promotes malignant progression of hepatocellular carcinoma via downregulating CELF2 through the PI3K\/Akt pathway","volume":"24","author":"Wu","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2025.123585_bb0155","article-title":"LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma","volume":"11(8):676","author":"Xie","year":"2020","journal-title":"Cell Death Dis."},{"issue":"29","key":"10.1016\/j.lfs.2025.123585_bb0160","doi-asserted-by":"crossref","first-page":"27176","DOI":"10.18632\/oncotarget.4870","article-title":"Association of CELF2 polymorphism and the prognosis of nasopharyngeal carcinoma in southern Chinese population","volume":"6","author":"Guo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2025.123585_bb0165","doi-asserted-by":"crossref","unstructured":"Lin N, Chen L, Zhang Y, et al. KIF4A promotes tumor progression of bladder cancer via CXCL5 dependent myeloid-derived suppressor cells recruitment. Sci Rep. Apr 10 2022;12(1):6015. doi:https:\/\/doi.org\/10.1038\/s41598-022-10029-x.","DOI":"10.1038\/s41598-022-10029-x"},{"issue":"5","key":"10.1016\/j.lfs.2025.123585_bb0170","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.3934\/mbe.2021313","article-title":"Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines","volume":"18","author":"Sun","year":"2021","journal-title":"Math. Biosci. Eng."},{"issue":"1","key":"10.1016\/j.lfs.2025.123585_bb0175","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1097\/CAD.0000000000001153","article-title":"Knockdown of CXCL5 inhibits the invasion, metastasis and stemness of bladder cancer lung metastatic cells by downregulating CD44","volume":"33","author":"Wang","year":"2022","journal-title":"Anti-Cancer Drugs"},{"issue":"2","key":"10.1016\/j.lfs.2025.123585_bb0180","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3892\/ijo.2015.3041","article-title":"CXCL5\/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K\/AKT-induced upregulation of MMP2\/MMP9","volume":"47","author":"Gao","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2025.123585_bb0185","doi-asserted-by":"crossref","unstructured":"Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell. Mar 17 2006;21(6):749\u201360. doi:https:\/\/doi.org\/10.1016\/j.molcel.2006.02.009.","DOI":"10.1016\/j.molcel.2006.02.009"},{"issue":"29","key":"10.1016\/j.lfs.2025.123585_bb0190","doi-asserted-by":"crossref","first-page":"22136","DOI":"10.1074\/jbc.M909572199","article-title":"Exon skipping in mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death","volume":"275","author":"Bingle","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"30","key":"10.1016\/j.lfs.2025.123585_bb0195","doi-asserted-by":"crossref","first-page":"19982","DOI":"10.1074\/jbc.M109.009928","article-title":"Participation of Xenopus Elr-type proteins in vegetal mRNA localization during oogenesis","volume":"284","author":"Arthur","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2025.123585_bb0200","doi-asserted-by":"crossref","unstructured":"Ma WJ, Cheng S, Campbell C, Wright A, Furneaux H. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem. Apr 5 1996;271(14):8144\u201351. doi:https:\/\/doi.org\/10.1074\/jbc.271.14.8144.","DOI":"10.1074\/jbc.271.14.8144"},{"issue":"24","key":"10.1016\/j.lfs.2025.123585_bb0205","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1111\/j.1742-4658.2006.05556.x","article-title":"IMP1 interacts with poly(a)-binding protein (PABP) and the autoregulatory translational control element of PABP-mRNA through the KH III-IV domain","volume":"273","author":"Patel","year":"2006","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.lfs.2025.123585_bb0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(00)00102-1","article-title":"A mechanism for translationally coupled mRNA turnover: interaction between the poly(a) tail and a c-fos RNA coding determinant via a protein complex","volume":"103","author":"Grosset","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2025.123585_bb0215","article-title":"circDHTKD1 promotes lymphatic metastasis of bladder cancer by upregulating CXCL5","volume":"8(1):243","author":"Lu","year":"2022","journal-title":"Cell Death Dis."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052500219X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052500219X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T09:23:56Z","timestamp":1744277036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052500219X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":43,"alternative-id":["S002432052500219X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123585","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CELF2 inhibits bladder cancer progression by decreasing the stability of CXCL5","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123585"}}